1 option
Clinical review report : indication : the treatment of major depressive disorder in adults. Vortioxetine hydrobromide (Trintellix) (Lundbeck Canada Inc.) / Canadian Agency for Drugs and Technologies in Health.
- Format:
- Book
- Author/Creator:
- Canadian Agency for Drugs and Technologies in Health, author, issuing body.
- Language:
- English
- Subjects (All):
- Outcome assessment (Medical care).
- Outcome assessment (Medical care)--Methodology.
- Physical Description:
- 1 online resource
- Edition:
- Corrected edition.
- Place of Publication:
- Ottawa, ON : CADTH, 2020.
- Summary:
- The objective of this report was to perform a systematic review of the beneficial and harmful effects of vortioxetine 5 mg, 10 mg, and 20 mg oral tablets for the treatment of Major depressive disorder in adults.
- Notes:
- Description based on publisher supplied metadata and other sources.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.